The evolution of virulence traits is central for the emergence or re-emergence of microbial pathogens and for their adaptation to a specific host 1-5 . Typhoid toxin is an essential virulence factor of the human-adapted bacterial pathogen Salmonella Typhi 6,7 , the cause of typhoid fever in humans 8-12 . Typhoid toxin has a unique A 2 B 5 architecture with two covalently linked enzymatic 'A' subunits, PltA and CdtB, associated with a homopentameric 'B' subunit made up of PltB, which has binding specificity for the N-acetylneuraminic acid (Neu5Ac) sialoglycans 6,13 prominently present in humans 14 . Here, we examine the functional and structural relationship between typhoid toxin and ArtAB, an evolutionarily related AB 5 toxin encoded by the broad-host Salmonella Typhimurium 15 . We find that ArtA and ArtB, homologues of PltA and PltB, can form a functional complex with the typhoid toxin CdtB subunit after substitution of a single amino acid in ArtA, while ArtB can form a functional complex with wild-type PltA and CdtB. We also found that, after addition of a single-terminal Cys residue, a CdtB homologue from cytolethal distending toxin can form a functional complex with ArtA and ArtB. In line with the broad host specificity of S. Typhimurium, we found that ArtB binds human glycans, terminated in N-acetylneuraminic acid, as well as glycans terminated in N-glycolylneuraminic acid (Neu5Gc), which are expressed in most other mammals 14 . The atomic structure of ArtB bound to its receptor shows the presence of an additional glycan-binding site, which broadens its binding specificity. Despite equivalent toxicity in vitro, we found that the ArtB/PltA/CdtB chimaeric toxin exhibits reduced lethality in an animal model, indicating that the host specialization of typhoid toxin has optimized its targeting mechanisms to the human host. This is a remarkable example of a toxin evolving to broaden its enzymatic activities and adapt to a specific host.
PltA with their homologues in other bacteria, the Cys residues involved in tethering them to form typhoid toxin are unique to these two subunits ( Fig. 1a and Supplementary Fig. 1 ). These observations suggest that the evolution of this multi-subunit toxin is likely to be relatively recent. In support of this hypothesis, homologues of each of the components of typhoid toxin are encoded within various Salmonella enterica subspecies as components of other toxins 17, 18 . For example, available genome sequencing data indicate the presence of an intact locus encoding all the CDT components, including CdtB in Salmonella Arizonae and Diarizonae 18 . Furthermore, certain strains of S. Typhimurium encode the toxin ArtAB, which exhibits very significant amino-acid sequence similarity to the PltA and PltB components of typhoid toxin ( Fig. 1a and Supplementary  Figs. 1 and 2) 15 . A degraded copy of the artAB locus is present in several S. enterica serovars 15 . Because Salmonella can readily exchange genetic materials across different serovars and strains, the presence of the different components of typhoid toxin in different Salmonella lineages, sometimes within mobile genetic elements, provides a framework through which typhoid toxin could have emerged.
We therefore investigated the potential evolutionary relatedness between ArtAB and typhoid toxin. We introduced a Cys residue in ArtA (ArtA R214C ) at the equivalent position of the Cys residue in PltA (PltA C214 ) that forms a disulfide bond with CdtB, co-expressed it with ArtB and CdtB, and examined their ability to form a complex. We found that ArtB, ArtA R214C and CdtB formed a complex in the predicted stoichiometry of 5:1:1 (Fig. 1b,c) . Importantly, addition of a reducing agent resulted in the dissociation of CdtB from ArtA (Fig. 1b,c) , demonstrating that the assembled complex has an equivalent architecture to that of typhoid toxin. We then tested the ability of the 'B' subunit ArtB to form a complex with PltA and CdtB, the two A subunits from typhoid toxin. We found that co-expression of all these components led to the assembly of a stable complex of a size consistent with that of an ArtB 5 -PltA-CdtB complex ( Fig. 1d and Supplementary Fig. 3 ). We then examined the functionality of the resulting chimaeric toxins by testing their CdtBdependent toxicity when applied to cultured cells. We found that, consistent with the formation of stable complexes ( Supplementary  Fig. 4 ), the CdtB-dependent toxic activity of the different chimaeric toxins was similar to that of typhoid toxin (Fig. 1e ). We also examined the ability of a homologue of CdtB from the S. diarizonae CDT to form a complex with ArtA and ArtB (Fig. 1e ). We found that, after addition of single Cys residue as its last amino acid, CdtB Cys276 was able to form a functional complex with ArtA and ArtB (Fig. 1e ). Taken together, these results demonstrate a very close structural Evolution of host adaptation in the Salmonella typhoid toxin Xiang Gao 1 , Lingquan Deng 2,4 , Gabrielle Stack 1 , Hai Yu 3 , Xi Chen 3 , Yuko Naito-Matsui 2 , Ajit Varki 2 and Jorge E. Galán 1 * Letters NATure MICroBIoloGy relationship among the components of these evolutionary related toxins and, more importantly, a remarkable plasticity to form functional chimaeric complexes, which probably facilitates the evolution of this toxin family.
Typhoid toxin exhibits exquisite preference for human-enriched Neu5Ac-terminated sialoglycans on surface glycoproteins, which serve as its receptors 13 . The amino-acid sequence similarity between PltB and ArtB ( Supplementary Fig. 2 
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NATure MICroBIoloGy also bind sialoglycans. Consistent with this hypothesis, removal of surface sialic acids from cultured cells reduced ArtB binding ( Fig. 2a and Supplementary Fig. 5 ). Because ArtAB is encoded by the broad-host-range S. Typhimurium, we hypothesized that the binding specificity of ArtB may differ from that of the human-adapted typhoid toxin. To test this hypothesis we probed the ability of fluorescently labelled ArtB to bind a diverse group of glycans arrayed on a solid surface. We found that, similar to typhoid toxin, ArtB was able to bind a diverse group of sialylated glycans with the consensus structure Neu5Acα 2-3Galβ 1-3/-4Glc/GlcNAc ( Fig. 2b and Supplementary Table 1 ). ArtB was also able to bind an additional group of sialylated glycans with the consensus Glycan no. Table 1 ). c, Comparison of ArtB-binding to paired Neu5Ac-and Neu5Gc-terminated glycans. The y-axis values represent the normalized average r.f.u. from four independent experiments and the x-axis indicates glycan numbers (Supplementary Table 2 ).
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Neu5Acα 2-6Gal/GalNAc, which typhoid toxin did not ( Fig. 2b and Supplementary Table 1 ). Importantly, however, unlike typhoid toxin, ArtB was also able to bind Neu5Gc-terminated glycans ( Fig. 2c and Supplementary Table 2 ). The broad binding specificity of ArtB is entirely consistent with the broad host range of the S. enterica serovar that harbours it.
We have previously shown that a single amino-acid substitution in the glycan-binding site of PltB (PltB S35A ) completely abolishes the ability of typhoid toxin to bind its glycan receptors and to intoxicate human cells 6 . However, we found that, in contrast to PltB, the equivalent mutation in ArtB (ArtB S31A ) retained a significant ability to bind cultured cells ( Supplementary Fig. 6 ). These results suggested substantial differences between the mechanisms of glycan binding in ArtB and PltB. To gain insight into the structural basis for the binding specificity of ArtB, we determined its atomic structures alone (at 2.3 Å resolution, Fig. 3a ) or bound to its glycan receptor Neu5Acα 2-3Galβ 1-4Glc (at 2.2 Å resolution, Fig. 3b and Supplementary Table 3 ). For comparison, we also solved the structure of PltB bound to the same glycan ( Fig. 3c ). In the crystal, each asymmetric unit of ArtB contained 10 molecules organized into two homopentamers, as predicted by its homology to other AB 5 toxins. In each of the pentamers, the ArtB protomer shows a typical oligosaccharide-binding fold located on the side of the pentamer, which corresponds to the equivalent binding site observed in the PltB structure. Clear electron density corresponding to the Neu5Acα 2-3Galβ was observed at this site in two of the five subunits of the ArtB and in three of the PltB pentamers ( Fig. 3a -c). The other sites were occupied by 2-(N-morpholino)ethanesulfonic acid (present in the crystallization buffer), which exhibits a similar structure to Neu5Ac. A close-up view of the ArtB canonical glycan-binding site shows that the Neu5Ac moiety interacts through multiple direct hydrogen bonds and water-mediated hydrogen bonds with Asn27, Tyr29, Gln30, Ser31, Arg59 and Asn65 in ArtB (Fig. 3d ). In addition, the Neu5Ac ring makes a hydrophobic contact with the aromatic ring of Tyr29. Overall, the arrangement of Neu5Ac and the interactions between Neu5Ac and ArtB are very similar to what is seen in PltB, which makes contact with the glycan moiety with an equivalent interaction involving Tyr33, Tyr34, Ser35, Lys59 and Thr65 ( Supplementary Fig. 7 ). However, ArtB has a Tyr103 that is absent from PltB (Fig. 3d ). The corresponding residue in the related toxin SubB has been shown to form a critical hydrogen bond with the extra hydroxyl group of Neu5Gc 19 . This structural feature is consistent with the observation that ArtB, like SubB, can also bind glycans terminated with Neu5Gc.
Surprisingly, an additional unambiguous glycan density was detected away from the predicted glycan-binding site of the ArtB pentamer in three or four out of the five protomers in different pentamers ( Fig. 3b ). No glycan density was detected at an equivalent position of PltB. At this additional glycan-binding site, ArtB makes contact with both the Neu5Ac and Gal moieties in Neu5Acα 2-3Galβ 1-4Glc through multiple interactions. For example, Ser45, Gly46, Phe75, Gly76, Lys79, Val107, Thr109 and Asp110 interact with the Neu5Ac moiety through multiple direct hydrogen bonds and watermediated hydrogen bonds. In addition, the aromatic ring of Phe75 makes hydrophobic contact with the ring structure of Neu5Ac, and Thr109 makes contact with the Gal moiety of Neu5Acα 2-3Galβ 1-4Glc through hydrogen bonding ( Fig. 3e ). Comparison of this additional glycan-binding site in ArtB with the equivalent surface in PltB reveals the presence in ArtB of a spoon-like structure critical for ligand binding, which is absent in PltB (Fig. 3f ). Amino-acid sequence alignment of this region of ArtB with the equivalent region in PltB showed the presence of a unique five-amino-acid insertion in ArtB (Fig. 3g) , which is responsible for the structural features associated with glycan binding. Comparison of the atomic structures of the receptor-bound and apo forms of ArtB indicates that, similar to PltB, binding to its glycan receptors does not result in detectable conformational changes ( Supplementary Figs. 8 and 9 ). Taken together, these findings indicate that ArtB has an additional glycan-binding site that may contribute to its expanded glycanbinding repertoire and that may have been eliminated from typhoid toxin by the introduction of a small deletion during the process of its adaptation to humans.
The residual glycan-binding activity of the ArtB S31A mutant coupled to the finding of a second glycan-binding site in ArtB prompted us to explore the potential specific contribution of each one of these sites to its overall glycan-binding activity. We generated and purified ArtB S31A , ArtB S45A single mutants as well as ArtB S31A/S45A double mutant proteins ( Supplementary Fig. 10 ) and compared their ability to bind cultured epithelial cells. We found that, in comparison to wild-type ArtB, the binding of ArtB S31A and ArtB S45A was reduced but not abrogated. In contrast, the binding of the ArtB S31A/S45A double mutant was undetectable ( Supplementary Fig. 11 ). These observations suggest that both sites contribute to ArtB binding to cultured cells. We then examined the binding of the different ArtB mutants in a customized glycan array. We found that the ArtB S45A mutant exhibited less residual glycan-binding activity than ArtB S31A (Supplementary Fig. 12 and Supplementary Table 3 ), indicating that the ArtB Ser45 site plays a more prominent role in glycan binding. Importantly, comparison of the binding profiles of the ArtB S31A and ArtB S45A mutants indicated that the ArtB Ser45 site exhibits binding preference for glycans terminated in Neu5Ac-α 2-6Gal/GalNAc (Supplementary Fig. 13 and Supplementary Table 4 ), a binding specificity absent in PltB 13 . Furthermore, we found that both ArtB mutants retained the ability to bind Neu5Gc-terminated glycans, indicating that both sites contribute to this expanded binding specificity ( Supplementary Fig. 14 and Supplementary Table 5 ). To further explore the impact of delivering the typhoid toxin-associated toxic activities through the different ArtB glycan-binding sites, we assembled chimaeric toxins consisting of wild-type and different mutants of ArtB (ArtB S31A , ArtB S45A or ArtB S31A/S45A ) in complex with PltA and CdtB ( Supplementary Fig. 15 ) and tested their toxic and binding activities in cultured human (displaying Neu5Acterminated glycans) and mouse (displaying Neu5Gc-and Neu5Acterminated glycans) cells. We found that, relative to one another, PltB exhibited greater binding to human cells, while ArtB exhibited higher binding to mouse cells ( Fig. 4a ). Although the chimaeric and typhoid toxins exhibited similar toxic activity to mouse cells ( Fig. 4b and Supplementary Fig. 16 ), typhoid toxin showed more toxicity towards human cells ( Fig. 4b ). We also found that both ArtB glycan-binding sites played an important role in toxin delivery, because each of the individual mutants exhibited a significant reduction in toxicity, and simultaneous introduction of mutations in both sites resulted in the complete loss of toxicity (Fig. 4c ). Taken together, these results indicate that the presence of an additional glycan-binding site broadens the glycan-binding specificity of ArtB relative to PltB.
We compared the toxicity of typhoid toxin with that of the ArtB/ PltA/CdtB chimaera in an animal model of intoxication. Despite equivalent in vitro toxic activity ( Fig. 4b and Supplementary  Fig. 16 ), administration of the same amount of toxin to C57BL/6 mice resulted in a more rapid death in animals receiving typhoid toxin than those receiving the ArtB/PltA/CdtB chimaera toxin ( Supplementary Fig. 17 ). Because Cmah expression in C57BL/6 mice is variable, these mice display both Neu5Ac-and Neu5Gcterminated glycans 20 . We therefore compared the toxicity of the different toxin preparations in Cmah −/− mice, which display Neu5Acterminated human-like sialoglycans 20 . In addition, we constructed a transgenic mouse that constitutively expresses Cmah under a strong promoter and therefore almost exclusively displays Neu5Gcterminated glycans (Fig. 4d,e and Supplementary Figs. 18 and 19 ). We found that, as predicted by its expanded glycan-binding specificity, the chimaeric ArtB/PltA/CdtB toxin displayed toxicity to the
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Cmah transgenic mice, while, as predicted by its binding specificity 13 , typhoid toxin did not ( Fig. 4f,g) . Surprisingly, however, despite its expanded binding specificity, the chimaeric toxin exhibited significantly less lethality than typhoid toxin for Cmah −/− mice. Furthermore, there were clear differences in the course of intoxication, as the mice receiving the ArtB/PltA/CdtB chimaeric toxin 
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NATure MICroBIoloGy did not show signs of stupor, but this was readily apparent in mice that received typhoid toxin. In contrast, leukopenia was apparent in all mice regardless whether they received typhoid toxin or the chimaeric toxin ( Supplementary Fig. 20) . These results indicate that, although typhoid toxin has narrowed its receptor-binding specificity, the process of host adaptation has resulted in heightened toxicity, presumably by gaining efficiency in the targeting of specific tissues and/or in its escape from soluble sialylated decoy ligands 21 .
Taken together, this study indicates that typhoid toxin may have evolved from an ArtAB-like ancestor in at least two steps. One step involved the incorporation of an additional active subunit to an already existing AB 5 toxin by evolving specifically positioned Cys residues to coordinate the linking of PltA to CdtB by a disulfide bond. The interface between PltA and CdtB buries only ~950 Å 2 , and CdtB is released from the toxin under reducing conditions, indicating that the disulfide bond is all that maintains the tethering of these two subunits to one another. Indeed, simply adding a terminal Cys residue to a CdtB homologue from a S. diarizonae CDT was sufficient to form a functional complex with ArtAB. The other step may have involved the narrowing and optimization of its glycan-binding site to maximize the toxin's effectiveness in its human host. In fact, the locus that encodes a typhoid toxin homologue in S. diarizonae contains two pltB homologues, pltB Sdiar-1 , which exhibits very close amino-acid and structural similarity to S. Typhi PltB, and pltB Sdiar-2 , a more divergent homologue that is more related to ArtB ( Supplementary Figs. 21-24 ). Notably, we found that, unlike typhoid toxin, chimaeric toxins assembled with either of these homologues were able to intoxicate cells displaying either Neu5Acor Neu5Gc-terminated glycans ( Supplementary Figs. 25 and 26 ). However, a chimaeric toxin assembled with pltB Sdiari-1 exhibited more toxicity to cells displaying Neu5Ac-terminated glycans, while a chimaeric toxin assembled with pltB Sdiari-2 showed the opposite preference ( Supplementary Figs. 25 and 26) . It is therefore possible that PltB Sdiari-1 and PltB Sdiari-2 represent an intermediate step in the evolution of S. Typhi's PltB from an ArtB-like ancestor. In summary, these findings describe a remarkable example of virulence factor evolution in which relatively minor genetic changes coupled to horizontal gene exchange within the same bacterial species may have led to the emergence of a powerful toxin exquisitely adapted to the human host.
Methods
Toxin expression and purification. Coding sequences for artA and artB were amplified from S. enterica serovar Typhimurium DT104 genomic DNA and cloned into the expression vector pET28b. Coding sequences for pltB homologues from S. diarizonae were amplified directly from bacterial cell lysates and cloned into the expression vector pET28b. Expression and purification of ArtB, ArtB chimaeric toxin, PltB sdiar chimaeric toxin and typhoid toxin were carried out as previously described 6 . Plasmids expressing ArtB point mutations were constructed using standard recombinant DNA techniques.
Crystallization. The expression and purification of C-terminal His 6 -tagged ArtB and PltB used for crystallization have been described previously 6 . Full-length ArtB protein (5 mg ml −1 ) was used to perform initial spare matrix crystal screening with a crystallization robot at the Yale University School of Medicine Structural Biology Core facility. After optimization trials, the ArtB crystals were grown at room temperature using the hanging-drop vapour-diffusion method, mixing 1 µ l protein with 1 µ l reservoir solution consisting of 44% (wt/vol) PEG200, 0.1 M calcium chloride and 0.1 M MES, pH 5.5. Crystals appeared in ∼ 3 days and matured in ∼ 1 week. To obtain 3′ -sialyllactose (3′ SL)-bound ArtB crystals, purified ArtB protein was mixed with 5 mM 3′ SL before setting up crystallization trays. The crystals used to collect diffraction data were grown in the presence of 35% (wt/vol) PEG200, 0.1 M calcium chloride and 0.1 M MES buffer, pH 5.5. To grow 3′ SL-bound PltB crystals, purified protein was mixed 5 mM of 3′ SL in the presence of 26% (wt/vol) PEG1500, 0.1 M sodium acetate, pH 4.6.
X-ray data collection and structure determination. X-ray data were collected at a wavelength of 1.5418 Å on a Rigaku Homelab system at the Yale University Chemical and Biophysical Instrumentation Center (http://cbic.yale.edu) or at the Yale University School of Medicine X-ray Crystallography Core Facility. Data were integrated and scaled using the HKL-2000 22 or Mosflm 23 software packages. Further processing was performed with programs from the CCP4 suite. The apo and 3′ SL bound ArtB and PltB structures were determined by molecular replacement using PHASER 24 with the atomic coordinates of PltB (Protein Data Bank (PDB) ID 4RHR) as the initial search model. To complete the model, manual building was carried out in COOT. Figures were prepared using PyMol 25 . Structure refinement was done by PHENIX 26 . The data collection and refinement statistics are summarized in Supplementary Table 6 . Coordinates for the atomic structures have been deposited in the RCSB PDB under numbers 5WHV, 5WHT and 5WHU (pending; http://www.rcsb.org/pdb/explore.do?structureId= 4RHS).
Alexa 555 and Oregon Green 488 labelling. Purified wild-type PltB, ArtB and different ArtB mutants were fluorescently labelled with Alexa-555 or Oregon Green 488 (OG488, Invitrogen) according to the vendor's instructions. Purified PltB, ArtB and its mutants (2 mg ml −1 in 500 μ l of 20 mM HEPES buffer, pH 8.1) were incubated for 1 h at room temperature with reactive dyes, and applied to the desalt spin columns to separate dye-protein conjugates from the free dyes.
Glycan microarray analysis. Glycan microarray analysis was carried out as previously described 13 . Briefly, glycan microarrays were fabricated using epoxidederivatized glass slides, as previously described 27 . Printed glycan microarray slides were blocked by ethanolamine, washed and dried, and then fitted in a multiwell microarray hybridization cassette (ArrayIt) to divide into subarrays. The subarrays were blocked with ovalbumin (1% wt/vol) in PBS (pH 7.4) for 1 h at room temperature in a humid chamber with gentle shaking. Subsequently, the blocking solution was discarded, and the appropriate dilutions of the different Alexa Fluor 555-labelled protein samples (64 µ g ml −1 ) were added to each subarray. After incubation for 2 h at room temperature with gentle shaking, the slides were extensively washed to remove nonspecifically bound proteins. The developed glycan microarray slides were then dried and subjected to scanning by a Genepix 4000B microarray scanner (Molecular Devices). Data analysis was carried using the Genepix Pro 7.0 analysis software (Molecular Devices).
Mammalian cell culture conditions. Henle-407 human intestinal epithelial cells (Roy Curtiss Laboratory Collection), HEK293T cells, mouse-embryo fibroblasts (MEFs) and NIH3T3 cells (from the American Type Culture Collection) were cultured in DMEM containing 10% fetal bovine serum (FBS) at 37 °C in a cell culture incubator with 5% CO 2 . All cell lines were routinely tested for the presence of mycoplasma using a standard PCR method. The cells were frequently checked for their morphological features, growth characteristics and functionalities, but were not authenticated by short tandem repeat (STR) profiling. Cells were split into 12-well plates at a cell density of 2.5 × 10 4 cells per well for the intoxication assays or at 2 × 10 5 cells per well for the toxin-binding assay. The next day, the cells were used for the different assays as described in the following.
Metabolic incorporation of Neu5Ac or Neu5Gc. Metabolic incorporation of
Neu5Ac or Neu5Gc was carried out as previously described 13 . Briefly, a stock solution containing 50 mM Neu5Ac or Neu5Gc was freshly prepared in DMEM medium, pH 7.0. Henle-407 cells (1.5 × 10 5 ) were seeded onto 6-well culture plates in 3 ml medium containing 10 mM Neu5Ac or Neu5Gc. During the feeding period, the cells were continuously monitored and maintained below 80% confluence. After 3 days of growth, the cells were collected and seeded onto 12-well plates at a cell density of 2.5 × 10 4 cells per well in 1 ml medium containing 10 mM Neu5Ac or Neu5Gc. The next day, the cells were used for intoxication assays, as described in the following.
Toxin binding assay. Cultured cells were seeded in 12-well plates, and 16 h later were treated with different preparations of OG488-labelled PltB, ArtB or its mutants in Hank's Balanced Salt Solution for 30 min on ice. Cells were then washed three times with PBS, fixed with 2% paraformaldehyde, and ~10,000 cells were analysed by fluorescence-activated cell sorting (FACS) on a BD Accuri C6 flow cytometer. The toxin binding profile was then analysed using FlowJo cytometry software (Tree Star) ( Supplementary Fig. 27 ). When indicated, cells were treated with 2 µ l protein deglycosylation mix (NEB #P6039S; contains PNGase F, Oglycosidase, neuraminidase, β 1-4 galactosidase and β -N-acetylglucosaminidase) or 50 units of α 2-3,6,8 neuraminidase (NEB#P0720S) and incubated for 2 h at 37 °C before toxin-binding assay and flow cytometric analyses.
Mammalian cell intoxication assay. Cell cycle arrest after intoxication by the ArtB chimaeric or typhoid toxins was examined by flow cytometry as previously described 28 . Briefly, cells were treated with the different toxin preparations and, 66 h (for Henle-407) or 48 h (for NIH3T3) after treatment, cells were trypsinized, collected, washed and fixed overnight in ∼ 70% ethanol/PBS at − 20 °C. Fixed cells were washed with PBS and resuspended in 500 μ l of PBS containing 50 μ g ml −1 propidium iodide, 0.1 mg ml −1 RNase A, and 0.05% Triton X-100. After incubation for 30 min at 37 °C, cells were washed with PBS, resuspended in 500 μ l PBS, filtered and analysed (3,000-5,000 cells) by a flow cytometry on a BD Accuri C6 flow cytometer. The DNA content of treated cells was determined using FlowJo software ( Supplementary Fig. 28 ).
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Generation of a Neu5Gc-overexpressing Cmah transgenic mouse. A Cmah transgenic mouse overexpressing Neu5Gc was generated following standard approaches following the scheme depicted in Fig. 4 .
Mouse intoxication experiments.
Mouse lines have been previously described 13 , and all animal experiments were conducted according to protocols approved by Yale University's Institutional Animal Care and Use Committee. Seven-to ten-week old C57BL/6, Cmah −/− or Cmah transgenic (TG) mice were anaesthetized with 30% wt/vol isoflurane in propylene glycol and 100 µ l of toxin solution was administered via the retro-orbital route. Changes in behaviour, weight and survival of the toxininjected mice were closely monitored for the duration of the experiment. Blood samples were collected by cardiac puncture 4 days after toxin administration in Microtainer tubes coated with EDTA, kept at room temperature, and analysed within 2 h of blood collection using a HESKA Veterinary Hematology System. The number of animals used in each experiment was determined empirically using prior experience with equivalent types of experiment.
Structural modelling. Structural modelling was performed online using the SWISS-MODEL Server (https://swissmodel.expasy.org) with the PltB structure (PDB ID 4RHR) as template. The highest scored structure was selected for structural comparisons.
Statistical analysis. Mice were randomly allocated to different groups. Investigators were not blinded to the allocation during the experiments or to the outcome assessment. Two-tailed Student's t-tests were performed to determine the statistical significance for two group comparisons. Given the nature of the experiments and the types of sample, mouse weight loss was assessed with a nonparametric Mann-Whitney test and mouse survival was assessed with a Mantel Cox test (log-rank test). A p value of < 0.05 was considered to be statistically significant. All analyses were performed using GraphPad Prism (GraphPad software). Corresponding author(s): Jorge E. Galan
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